Therapeuticsmd, Inc. · NASDAQ:TXMD

Baselake Partners, LP reported a 6.80% stake in Therapeuticsmd, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 5, 2026

Baselake Partners, LP reported a 6.80% stake in Therapeuticsmd, Inc., 790,703 shares, as a passive investor on Jun 30, 2026. Filed Aug 5, 2026 (Schedule 13G/A).

Stake
6.80%
Shares
790,703
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Baselake Partners, LP6.80%790,703
Baselake Management, LLC6.80%790,703
David Paolella6.80%790,703

Source

View original at SEC

Related